Research collaboration aims to advance long-term outcomes in aesthetic medicine.
Merz Aesthetics has announced a landmark research partnership with NANOTEC focused on advancing aesthetic longevity—the durability and sustained outcomes of aesthetic treatments over time. The collaboration signals Merz's commitment to clinical evidence supporting extended treatment intervals and cumulative benefit narratives.
Aesthetic longevity has become a key competitive differentiator in the injectables and energy-device markets. Practices increasingly market treatment packages around sustained results, and payers and patients alike value data on how repeated treatments compound benefit. Merz's partnership likely targets both its toxin and filler lines as well as its Ultherapy ultrasound platform.
Merz invests in clinical evidence for sustained aesthetic outcomes.
For practice owners, research partnerships of this scale often precede new clinical claims, reimbursement arguments, and marketing collateral that can support patient retention and justify premium pricing for maintenance protocols.
Source: original report ↗
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/mo
Join the owners who run ahead of the industry. Cancel anytime, one click.
